Sign In
Buy EW
$86.00
-1.66 (-1.89%)
At Close: Jun 03, 2026
What's Happening With Edward Lifesciences Stock?
08:00am, Monday, 20'th Sep 2021
A few months back we discussed that Edward Lifesciences stock may continue to see higher levels after rising 10% in a month following the positive developments around Resilia tissue valves. EW stock h
5 Good Companies With High Profitability
04:55pm, Friday, 17'th Sep 2021
According to the “Good Companies Screen,” one of several Premium screens under the All-in-One Screener, five stocks with high financial strength and profitability are Edwards Lifesciences Corp. (
4 High Ebitda Margin Stock Picks
03:02pm, Sunday, 05'th Sep 2021
If you want to have a higher chance to discover companies that are in good shape from a financial standpoint, you may want to consider the following four stocks, as their trailing 12-month (TTM) Ebitd
Edwards Lifesciences (EW) at a 52-Week High: What's Driving It?
10:45am, Thursday, 19'th Aug 2021
Investors are optimistic about Edwards Lifesciences (EW) on strong sales growth across all four product groups in the second quarter and raised 2021 guidance.
Final Trades: Estee Lauder, Chipotle, Abbvie & more
01:49pm, Tuesday, 17'th Aug 2021
The "Halftime Report" traders give their top picks to watch for the second half.
3 Medical Instruments Stocks Countering Industry Headwinds
11:28am, Wednesday, 04'th Aug 2021
The Zacks Medical - Instruments industry is growing on base business recovery. ISRG, IDXX and ALC are set to gain the most.
Amazon, Mastercard, Pinterest and More Friday Afternoon Analyst Upgrades and Downgrades
11:48am, Friday, 30'th Jul 2021
With the trading day nearly halfway over, the broad markets were pulling back into the weekend.
Edwards Lifesciences (EW) Beats on Q2 Earnings, Margins Up
11:24am, Friday, 30'th Jul 2021
Strong sales growth across all four products along with steady improvement in surgical procedure volumes during the second quarter drove Edwards Lifesciences' (EW) revenues.
Edwards Lifesciences Beats Q2 Earnings On Demand Recovery, Boosts FY2021 Guidance; Analysts Raise Price Target
08:13am, Friday, 30'th Jul 2021
Edwards Lifesciences (NYSE: EW), a cardio device company, reported Q2 earnings of $489.5 million, or $0.64, ahead of the consensus of $0.55. "Vaccine adoption in key regions has contributed to an in
Edwards Lifesciences Corporation (EW) CEO Mike Mussallem on Q2 2021 Results - Earnings Call Transcript
12:06am, Friday, 30'th Jul 2021
Edwards Lifesciences Corporation (EW) CEO Mike Mussallem on Q2 2021 Results - Earnings Call Transcript
Edwards Lifesciences: TAVR And TMTT Strengths Key Growth Levers
05:37pm, Wednesday, 28'th Jul 2021
Edwards Lifesciences presents with the economic pillars that round out a robust investment case. Central to the sell-side's thesis is EW's valuation, which we firmly believe is justified at 46X earnin
What's in Store for Edwards Lifesciences (EW) Q2 Earnings?
08:27am, Friday, 23'rd Jul 2021
Continued adoption of TruWave disposable pressure monitoring devices and progress in transfemoral EVOQUE and SAPIEN M3 platforms are likely to have driven Edwards Lifesciences' (EW) Q2 revenues.
Study Data Presented at TVT on the Economics of Minimalist TAVR, PARTNER 3 Bicuspid TAVR
03:15pm, Thursday, 22'nd Jul 2021
IRVINE, Calif., July 22, 2021 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) today announced that clinical and economic results from the 3M (multidisciplinary, multimodality, but minimalist) Transca
Edwards Lifesciences To Host Earnings Conference Call On July 29, 2021
07:05am, Thursday, 22'nd Jul 2021
IRVINE, Calif., July 22, 2021 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended June 30, 2021 after the market closes on Thursday, July 29,
Cardiology Space Gains Momentum in 2021: 5 Stocks to Focus on
08:17am, Friday, 18'th Jun 2021
These cardiology device stocks Medtronic (MDT), Boston Scientific (BSX), Edwards Lifesciences (EW), Merit Medical (MMSI), BD (BDX) are expected to continue their run over the next few months.
